Stage IVB Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Pertuzumab (DB06366)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05730712Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate CancerTreatment